Literature DB >> 19085270

Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.

Roger L Albin1, Robert A Koeppe, Shirley Rainier, John K Fink.   

Abstract

SPG3A/atlastin-1 gene mutations cause an autosomal dominant form of hereditary spastic paraplegia (SPG3A-HSP). We used positron emission tomography with [(11)C]DTBZ to assess nigrostriatal dopaminergic integrity in two unrelated adults with SPG3A-HSP due to the common SPG3A/atlastin-1 mutation, R239C. Nigrostriatal dopaminergic terminal density was normal. A difference from the human pattern of neurodegeneration is a critical limitation of this Drosophila model of SPG3A-HSP. This major difference between human SPG3A/atlastin-1 mutations and the Drosophila atl(l) phenotype has several possible explanations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085270      PMCID: PMC2743137          DOI: 10.1080/01677060802337307

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  9 in total

1.  Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

Authors:  R L Albin; R A Koeppe; R D Chervin; F B Consens; K Wernette; K A Frey; M S Aldrich
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

2.  Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia.

Authors:  Maria Muglia; Angela Magariello; Giuseppe Nicoletti; Alessandra Patitucci; Anna Lia Gabriele; Francesca Luisa Conforti; Rosalucia Mazzei; Manuela Caracciolo; Bonaventura Ardito; Marcello Lastilla; Gioacchino Tedeschi; Aldo Quattrone
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

3.  SPG3A: An additional family carrying a new atlastin mutation.

Authors:  A Tessa; C Casali; M Damiano; C Bruno; D Fortini; C Patrono; F Cricchi; M Valoppi; G Nappi; G A Amabile; E Bertini; F M Santorelli
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

4.  PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

Authors:  John R Adams; Hinke van Netten; Michael Schulzer; Edwin Mak; Jessamyn Mckenzie; Audrey Strongosky; Vesna Sossi; Thomas J Ruth; Chong S Lee; Matthew Farrer; Thomas Gasser; Ryan J Uitti; Donald B Calne; Zbigniew K Wszolek; A Jon Stoessl
Journal:  Brain       Date:  2005-08-04       Impact factor: 13.501

5.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia.

Authors:  X Zhao; D Alvarado; S Rainier; R Lemons; P Hedera; C H Weber; T Tukel; M Apak; T Heiman-Patterson; L Ming; M Bui; J K Fink
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

6.  Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila.

Authors:  Youngseok Lee; Donggi Paik; Sunhoe Bang; Jongkyun Kang; Bumkoo Chun; Seungbok Lee; Eunkyung Bae; Jongkyung Chung; Jaeseob Kim
Journal:  Neurobiol Aging       Date:  2006-10-09       Impact factor: 4.673

7.  Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin; Robert A Koeppe; Kristine A Wernette; Michael R Kilbourn; Satoshi Minoshima; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2006-01-18       Impact factor: 6.200

8.  Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin.

Authors:  Peng-Peng Zhu; Andrew Patterson; Brigitte Lavoie; Julia Stadler; Marwa Shoeb; Rakesh Patel; Craig Blackstone
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

9.  Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine.

Authors:  Genny Orso; Andrea Martinuzzi; Maria Giovanna Rossetto; Elena Sartori; Mel Feany; Andrea Daga
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

  9 in total
  2 in total

1.  Genome-Wide Analyses of Working-Memory Ability: A Review.

Authors:  E E M Knowles; S R Mathias; D R McKay; E Sprooten; John Blangero; Laura Almasy; D C Glahn
Journal:  Curr Behav Neurosci Rep       Date:  2014-12

2.  Striatal dopaminergic functioning in patients with sporadic and hereditary spastic paraplegias with parkinsonism.

Authors:  Ji Seon Kim; Jong Min Kim; Yu Kyeong Kim; Sang Eun Kim; Ji Young Yun; Beom S Jeon
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.